b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="phenaturepg" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC1950496/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>Virus detection and identification using random multiplex (RT)-PCR with 3\'-locked random primers</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1950496/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Virology Journal" /><meta name="citation_title" content="Virus detection and identification using random multiplex (RT)-PCR with 3\'-locked random primers" /><meta name="citation_authors" content="Amy L Clem, Jonathan Sims, Sucheta Telang, John W Eaton, Jason Chesney" /><meta name="citation_date" content="2007" /><meta name="citation_volume" content="4" /><meta name="citation_doi" content="10.1186/1743-422X-4-65" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC1950496/?report=abstract" /><meta name="citation_pmid" content="17598900" /><meta name="DC.Title" content="Virus detection and identification using random multiplex (RT)-PCR with 3\'-locked random primers" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Nature Publishing Group" /><meta name="DC.Contributor" content="Amy L Clem" /><meta name="DC.Contributor" content="Jonathan Sims" /><meta name="DC.Contributor" content="Sucheta Telang" /><meta name="DC.Contributor" content="John W Eaton" /><meta name="DC.Contributor" content="Jason Chesney" /><meta name="DC.Date" content="2007" /><meta name="DC.Identifier" content="10.1186/1743-422X-4-65" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Virus detection and identification using random multiplex (RT)-PCR with 3\'-locked random primers" /><meta property="og:type" content="article" /><meta property="og:description" content="PCR-based detection and identification of viruses assumes a known, relatively stable genome. Unfortunately, high mutation rates may lead to extensive changes in viral nucleic acid sequences making dedicated PCR primer use problematic. Furthermore, in ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1950496/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-phenaturepg.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC1950496/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC1950496/pdf/12985_2007_Article_278.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1A07F6E99A6BE10000000005F605F6.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=Nature%20Public%20Health%20Emergency%20Collection[filter]" class="navlink">Nature Public Health Emergency Collection</a></li><li class="accid">PMC1950496</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div class="banner-generic-logo-background inline_block"><div class="banner-journal-publisher-over-image"><div class="banner-journal-name bl-jtitle-phenaturepg">Virology Journal</div><div class="banner-publisher-name">Nature Publishing Group</div></div></div></div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">Virol J</span>. 2007; 4: 65. </span></div><div><span class="fm-vol-iss-date">Published online 2007 Jun 28. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1186%2F1743-422X-4-65" target="pmc_ext" ref="reftype=other&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1186/1743-422X-4-65</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC1950496</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/17598900">17598900</a></div></div></div></div><h1 class="content-title">Virus detection and identification using random multiplex (RT)-PCR with 3\'-locked random primers</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Clem%20AL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17598900" class="affpopup" co-rid="_co_idm139977988273328" co-class="co-affbox">Amy L Clem</a>,<sup></sup> <a href="/pubmed/?term=Sims%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17598900" class="affpopup" co-rid="_co_idm139977989956384" co-class="co-affbox">Jonathan Sims</a>,<sup></sup> <a href="/pubmed/?term=Telang%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17598900" class="affpopup" co-rid="_co_idm139978063416496" co-class="co-affbox">Sucheta Telang</a>,<sup></sup> <a href="/pubmed/?term=Eaton%20JW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17598900" class="affpopup" co-rid="_co_idm139978063414256" co-class="co-affbox">John W Eaton</a>,<sup></sup> and  <a href="/pubmed/?term=Chesney%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17598900" class="affpopup" co-rid="_co_idm139977990714304" co-class="co-affbox">Jason Chesney</a><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup></sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139977988273328"><h3 class="no_margin">Amy L Clem</h3><p>Molecular Targets Program, Medical Oncology, J.G. Brown Cancer Center, University of Louisville, Kentucky, USA </p><div>Find articles by <a href="/pubmed/?term=Clem%20AL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17598900">Amy L Clem</a></div></div><div id="_co_idm139977989956384"><h3 class="no_margin">Jonathan Sims</h3><p>Molecular Targets Program, Medical Oncology, J.G. Brown Cancer Center, University of Louisville, Kentucky, USA </p><div>Find articles by <a href="/pubmed/?term=Sims%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17598900">Jonathan Sims</a></div></div><div id="_co_idm139978063416496"><h3 class="no_margin">Sucheta Telang</h3><p>Molecular Targets Program, Medical Oncology, J.G. Brown Cancer Center, University of Louisville, Kentucky, USA </p><div>Find articles by <a href="/pubmed/?term=Telang%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17598900">Sucheta Telang</a></div></div><div id="_co_idm139978063414256"><h3 class="no_margin">John W Eaton</h3><p>Molecular Targets Program, Medical Oncology, J.G. Brown Cancer Center, University of Louisville, Kentucky, USA </p><div>Find articles by <a href="/pubmed/?term=Eaton%20JW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17598900">John W Eaton</a></div></div><div id="_co_idm139977990714304"><h3 class="no_margin">Jason Chesney</h3><p>Molecular Targets Program, Medical Oncology, J.G. Brown Cancer Center, University of Louisville, Kentucky, USA </p><div>Find articles by <a href="/pubmed/?term=Chesney%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17598900">Jason Chesney</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm139977991079776_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139977991079776_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm139977991079776_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139977991079776_ai" style="display:none"><div class="fm-affl" lang="en" id="Aff1">Molecular Targets Program, Medical Oncology, J.G. Brown Cancer Center, University of Louisville, Kentucky, USA </div><div><span class="fm-affl">Amy L Clem, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.ellivsiuol.esiwg@10melcla" class="oemail">ude.ellivsiuol.esiwg@10melcla</a></span>.</div><div><a href="#idm139977991079776aff-info">Contributor Information</a>.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm139977991079776_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2007 Apr 27; Accepted 2007 Jun 28.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm139977991079776_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; Clem et al; licensee BioMed Central Ltd. 2007</div><div class="license half_rhythm">This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC1950496/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="Abs1" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="Abs1title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h3 id="__sec1title">Background</h3><p id="__p1" class="p p-first-last">PCR-based detection and identification of viruses assumes a known, relatively stable genome. Unfortunately, high mutation rates may lead to extensive changes in viral nucleic acid sequences making dedicated PCR primer use problematic. Furthermore, in bioterrorism, viral consensus sequences can be genetically modified as a countermeasure to RT-PCR and DNA chip detection. Accordingly, there is a great need for the development of rapid and universal virus detection and identification technologies.</p></div><div id="__sec2" class="sec"><h3 id="__sec2title">Results</h3><p id="__p2" class="p p-first-last">We report herein that viral genomic DNA or RNA can be separated from host nucleic acids in plasma by filtration and nuclease digestion, and randomly amplified in a single PCR using a mixture of primers designed to be resistant to primer-dimer amplification (5\'-VVVVVVVVAA-3\', V = A, G or C; 3<sup>8</sup> or 6561 primers). We have termed this novel PCR method Random Multiplex (RT)-PCR since hundreds of overlapping PCR amplifications occur simultaneously. Using this method, we have successfullydetected and partially sequenced 3 separate viruses in human plasma without using virus-specific reagents (<em>i.e.,</em> Adenovirus Type 17, Coxsackievirus A7, and Respiratory Syncytial Virus B). The method is sensitive to ~1000 genome equivalents/ml and may represent the fastest means of detection of unknown viruses.</p></div><div id="__sec3" class="sec"><h3 id="__sec3title">Conclusion</h3><p id="__p3" class="p p-first-last">These studies suggest that the further development of random multiplex (RT)-PCR may lead to a diagnostic assay that can universally detect viruses in donated blood products as well as in patients suffering with idiopathic disease states of possible viral etiology.</p></div><div id="__sec4" class="sec sec-last"><h3 id="__sec4title">Electronic supplementary material</h3><p id="__p4" class="p p-first-last">The online version of this article (doi:10.1186/1743-422X-4-65) contains supplementary material, which is available to authorized users.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Human Plasma, Respiratory Syncytial Virus, Severe Acute Respiratory Syndrome, Yellow Fever, Severe Acute Respiratory Syndrome</span></div></div><div id="Sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec1title">Background</h2><p id="__p5" class="p p-first">Relatively benign viruses can be converted into highly virulent viruses via the introduction of genes of interest. For example, Ectromelia virus, a natural pathogen of mice that causes mousepox, recently was recombined with interleukin-4 as part of an effort to develop a live virus immuno-contraceptive vaccine. Surprisingly, the recombined virus caused 60% mortality in 2 strains of mice, whereas the wild type virus caused no death [<a href="#CR1" rid="CR1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844708298">1</a>]. A credible bioterrorism scenario might entail the release of such a recombined or chimeric virus tailored for maximum infectivity and pathogenicity but not readily detectable using our current "state-of-the-art" diagnostics (<em>i.e.,</em> PCR and micro-array chips.) Accordingly, there is a need for methods that can identify unknown viral pathogens and which can reveal extensive genomic information. Such methods would not only prove useful for our defense against bioterrorism, but also would improve our capacities to identify and control outbreaks of naturally occurring pathogenic viruses.</p><p id="__p6">The proven technology to rapidly detect and identify known human pathogens as potential causes of disease or as bioweapons is PCR [<a href="#CR2" rid="CR2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844708289">2</a>]. A recent example involved a case of fatal yellow fever (YF) in a traveler returning from Amazonas, Brazil in March, 2002 [<a href="#CR3" rid="CR3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845248165">3</a>]. The otherwise healthy 47-year-old male developed fever, headache, pancytopenia, coagulopathy, renal and liver failure. Pan-cultures were negative, and a peripheral smear yielded no plasmodia. Serological tests (IgG, IgM) performed at the CDC were negative for YF, dengue, St. Louis encephalitis, and other agents, but serum specimens (unfortunately examined only post-mortem) were positive for YF viral RNA as measured by RT-PCR [<a href="#CR3" rid="CR3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845248164">3</a>]. Subsequent attempts to isolate or culture the virus failed. This example highlights the superiority of PCR over other currently available methods. DNA chips that allow the simultaneous measurement of literally thousands of genes through hybridization are now being developed as the next-generation rapid diagnostic test for all known human pathogens [<a href="#CR4" rid="CR4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844708297">4</a>]. However, both of these technologies rely on a relatively stable genome, and several human pathogens display a high mutation rate (<em>e.g.,</em> HIV 2 &#x000d7; 10<sup>-5</sup>/base, 9 kB genome [<a href="#CR5" rid="CR5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844708291">5</a>]). Moreover, the ability to recombine "non-pathogenic" viruses <em>in vitro</em> introduces the potential not only for <em>de novo</em> pathogenicity but also for enhanced stealth. These considerations suggest that it may be impossible to design DNA micro-arrays which detect nucleic acids from all known and unknown viruses, including less obvious vehicles of bioterrorism such as adenovirus or rhinovirus recombined with a single gene for enhanced virulence. Accordingly, there is a great need for the development of techniques that enable the universal amplification of viral nucleic acids.</p><p id="__p7">There are 2 strategies to amplify genetic sequences with PCR without prior knowledge of the precise sequences. The first strategy relies on the degenerate binding of arbitrarily chosen primers to sample multiple cDNAs or genomic DNA species during PCR (two related methods are known as differential display and RNA Arbitrarily Primed PCR [RAP-PCR] [<a href="#CR6" rid="CR6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844708295">6</a>&#x02013;<a href="#CR8" rid="CR8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844708284">8</a>]). The amplicons range in size from ~50&#x02013;600 bp and overlap. RAP-PCR was recently used successfully to identify a novel human pneumovirus only after the virus had been cultured [<a href="#CR9" rid="CR9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844708285">9</a>]. These techniques yield an amplicon "fingerprint" and are generally used to compare two populations of nucleic acids. Accordingly, the pneumovirus was identified by comparing infected cells with non-infected cells [<a href="#CR9" rid="CR9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844708288">9</a>]. The other strategy is known as Sequence-Independent, Single-Primer Amplification (SISPA) and involves the directional ligation of a linker/adaptor oligonucleotide onto both ends of a target population of either DS DNA or DS cDNA (after reverse transcription from RNA) [<a href="#CR10" rid="CR10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844708292">10</a>]. The PCR is accomplished with primers specific for the linked adaptor molecule. SISPA, followed by extensive immunoscreening, enabled the cloning of the Norwalk agent genome from stool and Hepatitis G virus from plasma [<a href="#CR11" rid="CR11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844708286">11</a>]. Unfortunately, these techniques have not found great utility in the direct discovery or identification of novel viruses from human plasma or serum samples (unless accompanied by immunoscreening) because of the relatively high level of host genomic DNA. However, recent studies indicate that DNAse treatment of serum samples can degrade most of the host genomic DNA but not affect viral nucleic acids, which are protected by stable capsids [<a href="#CR12" rid="CR12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844708279">12</a>]. The combination of DNAse treatment with SISPA was successfully used to identify and sequence in their entirety 2 novel parvoviruses from bovine serum [<a href="#CR12" rid="CR12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844708280">12</a>].</p><p id="__p8">While the aforementioned PCR techniques are useful for the discovery of novel viruses, their utility to rapidly detect and identify unknown (or recombined) viruses is quite limited. RAP-PCR, random RT-PCR and SISPA are complicated multi-step procedures requiring infection of cultured cells, days to accomplish, expensive reagents and broad technical expertise. Accordingly, these methods have not found clinical utility for the rapid detection or identification of viral agents.</p><p id="__p9" class="p p-last">Here, we present a novel method for rapid virus detection and identification based on random multiplex (RT)-PCR using 3\'-locked random primers to avoid primer-dimer amplification. Once detected, virus amplification products can be shot-gun cloned and sequenced for identification. This method may prove useful for the rapid detection and identification of emerging or recombined viruses.</p></div><div id="Sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec2title">Results</h2><div id="Sec3" class="sec sec-first"><h3 id="Sec3title">Filtration and Nuclease Treatment Improves Viral DNA Amplification by Removing Host DNA and mRNA</h3><p id="__p10" class="p p-first-last">We hypothesized that random amplification of viral nucleic acids isolated from human plasma might provide a powerful new method to detect and identify novel and recombined viruses. Allander <em>et al.</em> recently found that subjecting bovine plasma to filtration (to remove cells) and DNAse treatment (to remove genomic DNA) was sufficient to separate viral nucleic acids from bovine nucleic acids and thus enable SISPA and cloning of novel viruses [<a href="#CR12" rid="CR12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844708296">12</a>]. The mechanism for this effect is related to the relative sensitivity of free-host DNA to DNAse treatment and to the relative insensitivity of virus capsid-protected DNA to DNAse treatment. We have found that human plasma is replete with free DNA and RNA species and thus opted to examine the potential of DNAse and RNAse treatment to isolate viral nucleic acids. We inoculated human plasma with Adenovirus Type 17 and examined the effects of filtration, DNAse treatment and RNAse treatment on Adenovirus Type 17 DNA and on human &#x003b2;-actin genomic DNA and mRNA, using (RT)-PCR. In Figure <a href="/pmc/articles/PMC1950496/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure1,</span></span><span>1</span></a>, we demonstrate that filtration, DNAse and RNAse treatment increases the efficiency of amplification of Adenovirus Type 17 DNA, whereas this combined treatment eliminates amplification of genomic &#x003b2;-actin (upper band) and &#x003b2;-actin cDNA (lower band). Although the addition of RNAse alone has little effect on the &#x003b2;-actin mRNA, the combination of DNAse and RNAse completely eliminates &#x003b2;-actin mRNA. We postulate that this finding may be related to the protection of RNA species by DNA:RNA hybrids. Nevertheless, these data demonstrate that we are able to remove host &#x003b2;-actin DNA and mRNA without degrading Adenovirus Type 17 DNA.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig1" co-legend-rid="lgnd_Fig1"><a href="/pmc/articles/PMC1950496/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139977986326640" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2007_Article_278_Fig1_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2007_Article_278_Fig1_HTML.jpg" src="/pmc/articles/PMC1950496/bin/12985_2007_Article_278_Fig1_HTML.jpg" /></div><div id="largeobj_idm139977986326640" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1950496/figure/Fig1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig1"><div><a class="figpopup" href="/pmc/articles/PMC1950496/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p11"><strong>Filtration and Nuclease Treatment Improves Viral DNA Amplification by Removing Host DNA and mRNA</strong>. Human plasma was inoculated with 1 &#x003bc;l of an Adenovirus Type 17 suspension, filtered and incubated for 2 hrs with either 10 u DNAse or 5 u RNAse as indicated. Remaining nucleic acids were purified with the QiaAmp UltrasSens Virus Kit and subjected to 1<sup>st</sup> strand cDNA synthesis and 50 cycles PCR using primers specific for either Adenovirus Type 17 or human &#x003b2;-Actin DNA (upper band; primers cross an intron) or cDNA (lower band). Amplicons were then visualized on an ethidium bromide impregnated agarose gel.</p></div></div></div></div><div id="Sec4" class="sec"><h3 id="Sec4title">5\'-VVVVVVVVAA-3\' Primers Enable Random Multiplex Amplification of Plasmid DNA</h3><p id="__p12" class="p p-first">We next designed a mixture of random primers that would enable the priming and amplification of all DNA or cDNA molecules, but that would be resistant to primer-dimer amplification. We chose 10 base pairs as a compromise length to simultaneously optimize hybridization and possible binding sites. <em>Taq</em> polymerase requires that the three 3\' bases of a primer be 100% complementary in order to enable efficient polymerization. We postulated that "locking" the 3\' end of the primers with 2 adenosines and not incorporating any thymidines into the upstream 5\' portion of the primers would prevent primer-dimer amplification (<em>i.e.,</em> 5\'-VVVVVVVVAA-3\'; where V = A, G or C). This primer design will limit the frequency of binding sites within a particular viral genome, but using the EditSeq DNA Editing application (DNAStar), we observed that primers within this mixture will bind every 200&#x02013;500 bp in both orientations in the 19 viral genomes that were examined, thus providing ample hybridization and amplification potential.</p><p id="__p13" class="p p-last">As a first test of these random primers we employed DNA plasmids of known sequence. We found that this mixture of primers enabled a continuum of discrete PCR products to be amplified from 4 different circular DNA plasmids (Figure <a href="/pmc/articles/PMC1950496/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure2A).</span></span><span>2A</span></a>). We shot-gun cloned these PCR products and confirmed that the amplified DNA had derived from the source plasmids (<em>data not shown</em>). In contrast, primers consisting of the sequence 5\'-NNNNNNNNNN-3\' (where N = A, T, G, or C) did not enable the production of discrete or clonable PCR amplicons (Figure <a href="/pmc/articles/PMC1950496/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure2A).</span></span><span>2A</span></a>). We then examined the ability of the V8AA primers to PCR amplify the plasmid, pBabe, and found that we could amplify as little as 100 fg (Figure <a href="/pmc/articles/PMC1950496/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure2B</span></span><span>2B</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig2" co-legend-rid="lgnd_Fig2"><a href="/pmc/articles/PMC1950496/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139978025462144" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2007_Article_278_Fig2_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2007_Article_278_Fig2_HTML.jpg" src="/pmc/articles/PMC1950496/bin/12985_2007_Article_278_Fig2_HTML.jpg" /></div><div id="largeobj_idm139978025462144" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1950496/figure/Fig2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig2"><div><a class="figpopup" href="/pmc/articles/PMC1950496/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p14"><strong>Random Multiplex PCR With 5\'-VVVVVVVVAA-3\' Primers Amplifies Circular Plasmid DNA</strong>. <strong>A</strong>. The indicated plasmids were amplified using random multiplex PCR with either 5\'-VVVVVVVVAA-3\' or 5\'-NNNNNNNNNN-3\' primers as indicated in the Methods section. <strong>B</strong>. The pBabe plasmid was diluted to the indicated amounts and amplified using random multiplex PCR with 5\'-VVVVVVVVAA-3\' primers.</p></div></div></div></div><div id="Sec5" class="sec"><h3 id="Sec5title">5\'-VVVVVVVVAA-3\' Primers Allow For the Random Multiplex Amplification of DNA from Human Plasma Inoculated with Adenovirus Type 17</h3><p id="__p15" class="p p-first-last">We inoculated 1 ml of human plasma with Adenovirus Type 17. The plasma was then filtered (220 nm filter) and incubated for 2 hours with nucleases. Remaining nucleic acids were purified and PCR amplified using the 5\'-VVVVVVVVAA-3\' primers. We found that this mixture of primers enabled discrete PCR products to be amplified in the human plasma that had been inoculated with Adenovirus Type 17 and treated with filtration, DNAse and RNase treatment (Figure <a href="/pmc/articles/PMC1950496/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure3).</span></span><span>3</span></a>). Importantly, we observed only minimal amplification products in the un-inoculated plasma. We next shot-gun cloned the PCR amplicons into the TOPO 2.1 cloning vector and PCR screened colonies from <em>E. coli</em> that had been transformed with mixtures of recombined plasmids. In the un-inoculated plasma samples, we were unable to clone and sequence the amplicons (<em>data not shown</em>). In subsequent experiments we have had variable success obtaining random multiplex PCR amplification from human plasma and have obtained only 7 sequences in total from un-inoculated plasma. These sequences did not align with any known sequences in NCBI Non-Redundant database (Blastn searches were conducted.) However, when we shot-gun cloned the DNA amplified from the Adenovirus 17-inoculated human plasma, we obtained 12 recombined vector clones, and all clones matched to Adenovirus Type 17 (see representative example, Figure <a href="/pmc/articles/PMC1950496/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure4).</span></span><span>4</span></a>). These data demonstrate that the combination of filtration, DNAse/RNAse treatment and V8AAmer Random Multiplex PCR allows for the detection and identification of Adenovirus Type 17 without using any virus-specific reagents such as primers, antibodies or microarray chips.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig3" co-legend-rid="lgnd_Fig3"><a href="/pmc/articles/PMC1950496/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139977988870560" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2007_Article_278_Fig3_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2007_Article_278_Fig3_HTML.jpg" src="/pmc/articles/PMC1950496/bin/12985_2007_Article_278_Fig3_HTML.jpg" /></div><div id="largeobj_idm139977988870560" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1950496/figure/Fig3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig3"><div><a class="figpopup" href="/pmc/articles/PMC1950496/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3">Figure 3</a></div><!--caption a7--><div class="caption"><p id="__p16"><strong>5\'-VVVVVVVVAA-3\' Primers Enable Random Multiplex Amplification of DNA from Human Plasma Inoculated with Adenovirus Type 17</strong>. 1 ml of human plasma was inoculated with 0&#x02013;5 &#x003bc;l of suspended Adenovirus Type 17 (ATCC), filtered and incubated for 2 hours with nucleases. Remaining nucleic acids were purified with the QiaAmp UltrasSens Virus Kit (Qiagen) and subjected to the random multiplex PCR with 5\'-VVVVVVVVAA-5\' primers as detailed in the Methods section. Amplicons were then visualized on an ethidium bromide impregnated agarose gel.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig4" co-legend-rid="lgnd_Fig4"><a href="/pmc/articles/PMC1950496/figure/Fig4/" target="figure" rid-figpopup="Fig4" rid-ob="ob-Fig4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139977987197376" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2007_Article_278_Fig4_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2007_Article_278_Fig4_HTML.jpg" src="/pmc/articles/PMC1950496/bin/12985_2007_Article_278_Fig4_HTML.jpg" /></div><div id="largeobj_idm139977987197376" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1950496/figure/Fig4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig4"><div><a class="figpopup" href="/pmc/articles/PMC1950496/figure/Fig4/" target="figure" rid-figpopup="Fig4" rid-ob="ob-Fig4">Figure 4</a></div><!--caption a7--><div class="caption"><p id="__p17"><strong>PCR Screening and Sequencing of Randomly Amplified Adenovirus Type 17 DNA</strong>. Randomly amplified DNA from Adenovirus 17-infected plasma was shot-gun ligated into pCR 2.1-TOPO and competent E. coli were transformed. Resultant colonies were screened for the presence of recombinant plasmid DNA (<strong>A</strong>) and plasmid DNA from positive colonies was then purified and sequenced (<strong>B</strong>). Sequence data from recombinant plasmid #9 (see *) was aligned to all sequence data in the Non-Redundant NCBI Database using the NCBI Nucleotide-Nucleotide BLAST (blastn) Search Algorithm (version 2.2.8) (<strong>C</strong>).</p></div></div></div></div><div id="Sec6" class="sec"><h3 id="Sec6title">Sensitivity of the Random Multiplex PCR Using 5\'-VVVVVVVVAA-3\' Primers</h3><p id="__p18" class="p p-first-last">The suspension of Adenovirus Type 17 received from the ATCC had not been quantified and the sensitivity of the random multiplex PCR method thus was uncertain. In order to generate a standard curve, we conducted real-time PCR of a known concentration of PCR-amplified Adenovirus Type 17 genomic template using Adenovirus Type 17-specific primers and found that we could detect as little as 10 copies/ml of template (<em>data not shown</em>). We then subjected the ATCC Adenovirus Type 17 suspension from the ATCC to real-time PCR using the same Adenovirus Type 17-specific primers and found that we could readily detect the genomic DNA (<em>data not shown</em>). Based on the real-time PCR generated from the known concentrations of Adenovirus Type 17 genomic template, we generated a standard curve plotting the concentration of Adenovirus Type 17 genome equivalents <em>versus</em> the cycle number when fluorescence passed the pre-set threshold (Ct; Figure <a href="/pmc/articles/PMC1950496/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure4A).</span></span><span>4A</span></a>). Based on this standard curve, we determined that the stock solution of Adenovirus Type 17 contained 1 &#x000d7; 10<sup>7</sup> genome equivalents/ml. We then titrated down the concentration of virus in human plasma and conducted the combination of filtration, DNAse/RNAse treatment and random multiplex PCR using the 5\'-VVVVVVVVAA-3\' primers. We found that the random multiplex (RT)-PCR method is sensitive to 1000 genome equivalents/ml (Figure <a href="/pmc/articles/PMC1950496/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure4B</span></span><span>4B</span></a>).</p></div><div id="Sec7" class="sec sec-last"><h3 id="Sec7title">Application of Random Multiplex PCR to RNA Viruses</h3><p id="__p19" class="p p-first-last">We postulated that the random multiplex PCR method would also detect RNA viruses if the viral nucleic acids were first subjected to 1<sup>st</sup> strand cDNA synthesis. We inoculated human plasma with the RNA virus Coxsackievirus A7 (CSV A7) and then filtered, treated with DNAse and RNAse, purified the remaining nucleic acids and conducted (RT)-PCR, using two commercially available reverse transcriptases (Omniscript and SuperScript II) and CSV A7 specific primers separated by either 200 bp or 1.4 Kb. We found that whereas Omniscript RT was more efficient at amplifying 200 bp cDNA species, SuperScript II RT was more efficient at amplifying 1.4 Kb fragments (Figure <a href="/pmc/articles/PMC1950496/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure5A).</span></span><span>5A</span></a>). Next, we used the 5\'-VVVVVVVVAA-3\' primers to random multiplex PCR amplify the cDNA and observed distinct albeit faint amplicons (Figure <a href="/pmc/articles/PMC1950496/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure5B).</span></span><span>5B</span></a>). We cloned the amplification products and found that the amplified DNA products matched the sequence of the cloned RNA genomes as determined by BlastN alignment searches of the NCBI Non-Redundant database (Figure <a href="/pmc/articles/PMC1950496/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure6).</span></span><span>6</span></a>). We were surprised that the cloned DNA from Coxsackievirus A7 aligned with the known sequence for Coxsackievirus A16 until we learned that the Coxsackievirus A7 strain had not been fully sequenced and is thus not in the NCBI Non-Redundant Database (search terms Coxsackievirus AND A7). Accordingly, we had amplified portions of the Coxsackievirus A7 genome that had not previously been sequenced (Figure <a href="/pmc/articles/PMC1950496/figure/Fig7/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig7" rid-ob="ob-Fig7" co-legend-rid="lgnd_Fig7"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure7).</span></span><span>7</span></a>). We also inoculated human plasma with Respiratory Syncytial Virus B and were able to amplify and identify genomic RNA using the 5\'-VVVVVVVVAA-3\' primers (<em>data not shown</em>). However, the PCR amplification efficiency was poor in both RNA viruses relative to the DNA virus, AV17, and we suspect that this may be related to the efficiency of the reverse transcriptases or the stability of the RNA.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig5" co-legend-rid="lgnd_Fig5"><a href="/pmc/articles/PMC1950496/figure/Fig5/" target="figure" rid-figpopup="Fig5" rid-ob="ob-Fig5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139977989300336" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2007_Article_278_Fig5_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2007_Article_278_Fig5_HTML.jpg" src="/pmc/articles/PMC1950496/bin/12985_2007_Article_278_Fig5_HTML.jpg" /></div><div id="largeobj_idm139977989300336" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1950496/figure/Fig5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig5"><div><a class="figpopup" href="/pmc/articles/PMC1950496/figure/Fig5/" target="figure" rid-figpopup="Fig5" rid-ob="ob-Fig5">Figure 5</a></div><!--caption a7--><div class="caption"><p id="__p20"><strong>Real-Time PCR Quantitation of Adenovirus Type 17 DNA Template</strong>. <strong>A</strong>. PCR-amplified genomic DNA from Adenovirus Type 17 was quantitated by spectrophotometry (OD 260 nm) and the genome equivalents/ml calculated based on Avogadro\'s number (6.02205 &#x000d7; 10<sup>23</sup>/mol). Real-time PCR was conducted with Adenovirus Type 17 specific primers using 10<sup>9</sup> to 10<sup>1</sup> genome equivalents/ml as template and then using 1 &#x003bc;l of the stock solution of Adenovirus Type 17 as template. A standard curve was produced based on the threshold cycle number of the tested concentrations of Adenovirus Type 17 DNA template and plotted compared to the threshold cycle number (C<sub>T</sub>) of the stock solution of Adenovirus Type 17. <strong>B</strong>. The indicated genome equivalents of Adenovirus Type 17 were added to 1 ml of human plasma, treated with 220 nm filtration and DNAse/RNAse digestion. Total nucleic acids then were purified, amplified by random multiplex PCR (50 cycles) and sequenced as described in the Methods section.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig6" co-legend-rid="lgnd_Fig6"><a href="/pmc/articles/PMC1950496/figure/Fig6/" target="figure" rid-figpopup="Fig6" rid-ob="ob-Fig6"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139977989869600" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2007_Article_278_Fig6_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2007_Article_278_Fig6_HTML.jpg" src="/pmc/articles/PMC1950496/bin/12985_2007_Article_278_Fig6_HTML.jpg" /></div><div id="largeobj_idm139977989869600" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1950496/figure/Fig6/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig6"><div><a class="figpopup" href="/pmc/articles/PMC1950496/figure/Fig6/" target="figure" rid-figpopup="Fig6" rid-ob="ob-Fig6">Figure 6</a></div><!--caption a7--><div class="caption"><p id="__p21"><strong>5\'-VVVVVVVVAA-3\' Primers Enable Random Multiplex Amplification of Viral RNA from Human Plasma Inoculated with Coxsackie Virus A7</strong>. <strong>A</strong>. 1 ml of human plasma was inoculated with 5 &#x003bc;l of suspended Coxsackie Virus A7 (ATCC), filtered and incubated for 2 hours with nucleases. Remaining nucleic acids were purified with the QiaAmp UltrasSens Virus Kit (Qiagen) and subjected to first strand cDNA synthesis using either Omniscript or Superscript reverse transcriptase. Virus-specific primers were used to amplify either a 200 bp or a 1.4 Kb portion of the viral genome. <strong>B</strong>. The same samples were then subjected to random multiplex PCR with 5\'-VVVVVVVVAA-5\' primers as detailed in the Methods section. Amplicons were then visualized on an ethidium bromide impregnated agarose gel.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig7" co-legend-rid="lgnd_Fig7"><a href="/pmc/articles/PMC1950496/figure/Fig7/" target="figure" rid-figpopup="Fig7" rid-ob="ob-Fig7"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139977986782144" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2007_Article_278_Fig7_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2007_Article_278_Fig7_HTML.jpg" src="/pmc/articles/PMC1950496/bin/12985_2007_Article_278_Fig7_HTML.jpg" /></div><div id="largeobj_idm139977986782144" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1950496/figure/Fig7/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig7"><div><a class="figpopup" href="/pmc/articles/PMC1950496/figure/Fig7/" target="figure" rid-figpopup="Fig7" rid-ob="ob-Fig7">Figure 7</a></div><!--caption a7--><div class="caption"><p id="__p22"><strong>PCR Screening and Sequencing of Randomly Amplified Coxsackie Virus A7 cDNA</strong>. Randomly amplified cDNA from Coxsackie Virus A7-infected plasma was shot-gun ligated into pCR 2.1-TOPO and competent E. coli were transformed. Resultant colonies were screened for the presence of recombinant plasmid DNA <strong>(A)</strong> and plasmid DNA from positive colonies was then purified and sequenced <strong>(B)</strong>. Sequence data from recombinant plasmid #7 (see *) was aligned to all sequence data in the Non-Redundant NCBI Database using the NCBI Nucleotide-Nucleotide BLAST (blastn) Search Algorithm (version 2.2.8).</p></div></div></div></div></div><div id="Sec8" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec8title">Conclusion</h2><p id="__p23" class="p p-first">In November 2002, an outbreak of atypical pneumonia occurred in Guangdong Province, People\'s Republic of China [<a href="#CR13" rid="CR13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848472913">13</a>, <a href="#CR14" rid="CR14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848472919">14</a>]. The disease did not respond to empirical antibiotic treatment, and no known bacterial or viral pathogens were identified using serological and (RT)-PCR analyses. The disorder was called Severe Acute Respiratory Syndrome (SARS), and by July 2003 it had caused 8439 reported cases and 812 fatalities [<a href="#CR13" rid="CR13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848472917">13</a>, <a href="#CR14" rid="CR14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848472912">14</a>]. In an effort to identify the causative agent of SARS, the WHO SARS Aetiology Study Group coordinated the distribution of information and infected materials and the analyses of the data amongst eleven separate laboratories [<a href="#CR14" rid="CR14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848472916">14</a>]. Researchers cultured fetal rhesus kidney cells with infected nasopharyngeal aspirates and then conducted random RT-PCR using the primer, 5\'-GCCGGAGCTCTGCAGAATTCNNNNNN-3\' for reverse transcription, and 5\'-GCCGGAGCTCTGCAGAATTC-3\' for PCR. Unique PCR products in the infected cell preparation were cloned and sequenced, and 57% homology was found with bovine Coronavirus[<a href="#CR13" rid="CR13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848472914">13</a>]. RT-PCR of hundreds of infected clinical specimens, using primers specific for the novel virus, confirmed the identification [<a href="#CR13" rid="CR13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848472918">13</a>, <a href="#CR14" rid="CR14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848472915">14</a>]. While this approach was successful, it is worthwhile to note that it required 5 months and 11 laboratories to identify the virus. By contrast, the procedures described herein are &#x02013; at least theoretically &#x02013; capable of identifying an unknown virus without the use of specially designed primers. Furthermore, is possible to at least partially identify an unknown agent within 2&#x02013;3 days in one laboratory without intermediate culture steps.</p><p id="__p24">In the current study, we have detected and identified 3 separate viruses (<em>i.e.,</em> Adenovirus Type 17, Coxsackievirus A7, Respiratory Syncytial Virus B), using the novel approach of random multiplex (RT)-PCR of purified viral nucleic acids. The detection was accomplished in 7 hours using only a micro-centrifuge and PCR machine and did not require any virus-specific reagents. The sensitivity is ~1000 genome equivalents/ml for Adenovirus Type 17 which is not as sensitive as virus-specific PCR (&#x0003c;50 genome equivalents/ml) but should be adequate for the detection of free virus in untreated individuals. Coupled with the potential for direct sequence information, we are confident that this approach may prove useful for our defense against acts of bioterrorism, as well as for the detection and characterization of novel viruses in blood products and in patients displaying hallmarks of infection (<em>e.g.,</em> leukocytosis, fever).</p><p id="__p25">Although we believe that the method is adequate in current form to test clinical specimens in a randomized, blinded diagnostic trial, we consider that certain alternative approaches may yield a method that has improved sensitivity and specificity. In particular, we intend to decrease the background amplification that has been variably observed in order to prevent false positives and to increase sensitivity by applying SYBR green fluorescence for DNA detection. Finally, we will apply the optimized approach to blood specimens from virally infected patients in order to detect unsuspected variables and to validate the method within the clinical environment.</p><p id="__p26" class="p p-last">Our long-term goal is to provide emergency room and primary care physicians with the ability to universally detect viruses in human plasma. The rationale is, in part, that if an emerging or recombined pathogenic virus were intentionally released into a population, then the ability of physicians to detect the pathogen will be crucial for containment. A second and related application of this technique involves identification of previously undescribed &#x02013; but naturally occurring &#x02013; viruses in patients suffering with idiopathic disease states of possible viral etiology. A third application of these procedures may be in the screening of blood bank blood just for the presence of virus. Although the precise identification of the virus requires cloning and sequencing, the amplification pattern will provide an immediate signature indicating the presence of virus. Most clinical laboratories that service emergency rooms and primary care clinics possess the ability to conduct RT-PCR for known viruses such as HIV, and the unmodified random multiplex (RT)-PCR method does not require any further technical expertise. In conclusion, the optimization and testing of the random multiplex (RT)-PCR technology should allow for the development of a universal virus detection assay that will vastly improve our collective defense against viral bioweapons and against emerging, heretofore unidentified natural viruses.</p></div><div id="Sec9" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec9title">Methods</h2><div id="Sec10" class="sec sec-first"><h3 id="Sec10title">PCR of plasmids using 5\'-VVVVVVVVAA-3\' and 5\'-NNNNNNNNNN-3\' primers</h3><p id="__p27" class="p p-first-last">Plasmids (10 ng each) pEGFP (Clontech), pSuperNeo (Oligoengine), Pet 30b (Calbiochem), and pBabe (Addgene) were added to a PCR mix containing (per reaction): 1 &#x003bc;l of 40 &#x003bc;M of one of the primers indicated (Oligos Etc), 2.5 &#x003bc;l 10&#x000d7; PCR buffer (Promega), 5 &#x003bc;l (5 mM) MgCl<sub>2</sub>, 1 &#x003bc;l (5 mM) dNTPs, 14 &#x003bc;l water, and 0.6 &#x003bc;l Taq polymerase (Promega). PCR was performed according to the following protocol on an Eppendorf Mastercycler Gradient: 95&#x000b0;C-2 minutes and then 94&#x000b0;C-30 seconds, 33&#x000b0;C-59 seconds, 34&#x000b0;C-6 seconds (increase in increments of 1&#x000b0;C for 6 seconds each up to 57&#x000b0;C for 6 seconds), 58&#x000b0;C-2 minutes (+ .3&#x000b0;/s), repeat 50 times, 37&#x000b0;C-5 minutes, 65&#x000b0;C-5 minutes (+ .3&#x000b0;/s), and then hold at 4&#x000b0;C. Products were run on a 1% agarose gel containing ethidium bromide and images were captured on a UVP, Bio-Doc It, gel documentation system.</p></div><div id="Sec11" class="sec"><h3 id="Sec11title">Viral samples</h3><p id="__p28" class="p p-first-last">Adenovirus Type 17 was purchased from ATCC (VR-1094). This virus is a dsDNA virus. The source was conjunctival scraping from a 1-year old female, Saudi Arabia, 1955. Coxsackievirus A7 W.P. Parker was purchased from ATCC (VR-166). This virus is a ssRNA virus. The source was stool of a 7-year old with fever, headache, sore throat, stiff neck, and back pain, New York, 1949. Respiratory syncytial virus was purchased from ATCC (VR-1580). This virus is a ssRNA, linear virus. The source was the respiratory secretions from a child with acute respiratory disease.</p></div><div id="Sec12" class="sec"><h3 id="Sec12title">Blood Plasma Isolation and Viral Separation</h3><p id="__p29" class="p p-first-last">10 ml of heparinized whole blood was placed into a 15 ml Falcon tube (BD Biosciences) and centrifuged at 1700 &#x000d7; g for 10 minutes. 250 &#x003bc;l of plasma layer was added to 250 &#x003bc;l room temperature 1&#x000d7; PBS and placed in a SPIN-X .22 micron, 2 ml centrifuge tube (Costar). Plasma was then inoculated with virus and the mixture was centrifuged at 2500 &#x000d7; g for 15 minutes. If any of the mixture remained above the filter, centrifugation was continued at higher speeds until all plasma had passed the filter into the collection tube. 500 &#x003bc;l of PBS was added to the filtered mixture and treated with 7 &#x003bc;l each of un-diluted Riboshredder (Epicentre) and Omnicleave (Epicentre). Treatment of samples with the RNAse and DNAse should cleave any DNA or RNA not protected by viral capsid. All samples were placed in a Thermomixer R (Eppendorf) at 37&#x000b0;C and shaken for 15 seconds every 3 minutes for 2 hours. Plasma was then ready for viral isolation.</p></div><div id="Sec13" class="sec"><h3 id="Sec13title">Isolation of Virus from Plasma</h3><p id="__p30" class="p p-first-last">1 ml of blood plasma &#x000b1; virus was cooled to room temperature and placed into a 2 ml tube. Viral isolation was carried out according to the manufacturer\'s protocol (Qiagen). Viral DNA or RNA was eluted off the column in a final volume of 30 &#x003bc;l elution buffer. This product was either used directly for random PCR or used in the reverse transcription reaction.</p></div><div id="Sec14" class="sec"><h3 id="Sec14title">Reverse Transcription of Viral RNA</h3><p id="__p31" class="p p-first-last">Reverse transcription was carried out according to the manufacturer\'s protocol either with the Omniscript RT (Qiagen) or SuperScript II RT (Invitrogen). The maximum amount of viral RNA was used in place of water for both reactions.</p></div><div id="Sec15" class="sec"><h3 id="Sec15title">Isolation and cloning of random PCR products</h3><p id="__p32" class="p p-first-last">The PCR of viral DNA isolated from whole blood was done according to the method described above utilizing the 5\'-VVVVVVVVAA-3\' primers. Products were run on a 1% agarose gel containing ethidium bromide. The bands which differed from the water control were excised and the DNA was extracted using the Qiaquick gel extraction kit (Qiagen). DNA was eluted off in a final volume of 20 &#x003bc;l elution buffer. The DNA was cloned into the TOPO cloning vector (Invitrogen) following the manufacturer\'s protocol and transformation was carried out in TOP 10 chemically competent <em>E. coli</em>. Resulting colonies were picked randomly and mixed with 20 &#x003bc;l PBS. 1 &#x003bc;l of this mixture was used in the PCR reaction using the universal M13 forward and reverse (1 &#x003bc;l of 10 &#x003bc;M) primers and 2 &#x000d7; PCR master mix (Promega). The following parameters were used for colony screening: 95&#x000b0;C-2 minutes, and then 36 cycles of 94&#x000b0;C-30 seconds, 55&#x000b0;C-30 seconds, 72&#x000b0;C-1 minute. PCR products were run out on a 1% agarose gel containing ethidium bromide. Those colonies which yielded products greater than 200 bp were grown in LB broth overnight and the DNA was isolated according to the manufacturer\'s protocol (Qiagen) eluting the DNA off in a final volume of 25 &#x003bc;l. DNA was sequenced using the universal M13 forward and reverse primers at the University of Louisville\'s core sequencing facility. Resulting sequences were screened using the BLAST program on the NCBI web site to determine sequence origin.</p></div><div id="Sec16" class="sec"><h3 id="Sec16title">PCR from Viral DNA or cDNA with Virus-specific Primers</h3><p id="__p33" class="p p-first">PCR was carried out with either viral DNA or cDNA using a 2&#x000d7; PCR Master Mix (Promega) and 1 &#x003bc;l of viral DNA. 1 &#x003bc;l of 10 &#x003bc;M primers was used for each reaction. The total volume was equal to 25 &#x003bc;l per reaction. The following parameters were used for viral-specific amplification: 94&#x000b0;C-5 minutes, 94&#x000b0;C-30 seconds, 55&#x000b0;C-30 seconds, 72&#x000b0;C-2 minutes, repeat 45 times, 72&#x000b0;C-7 minutes.</p><p id="__p34">Virus-Specific Primers (standard PCR)</p><p id="__p35">For generation of 200 bp fragment:</p><p id="__p36">Coxsackievirus forward primer (923): 5\'-TTATCAGAGATGGCAGCACC-3\'</p><p id="__p37">Coxsackievirus reverse primer (1105C): 5\'-CTTGTCCACCGCTGTAGCCT-3\'</p><p id="__p38">For generation of 1.4 Kb fragment:</p><p id="__p39">Coxsackievirus forward primer (923): 5\'-TTATCAGAGATGGCAGCACC-3\'</p><p id="__p40">Coxsackievirus reverse primer (2161C): 5\'-CATTGCCTGCATTCTGTTGG-3\'</p><p id="__p41">Virus-Specific Primers (For Real Time PCR)</p><p id="__p42">Coxsackievirus forward primer (937): 5\'-AGCACCACTGCAATCACCGA-3\'</p><p id="__p43">Coxsackievirus reverse primer (1094C): 5\'-CTGTAGCGTCAGTGTCAGGA-3\'</p><p id="__p44">Adenovirus forward primer (5770): 5\'-TGTAGGTGTAGGCCACGTGA-3\'</p><p id="__p45">Adenovirus reverse primer (6084C): 5\'-TCGCCAAGCTTCTCTCCAAC-3\'</p><p id="__p46">Template Production Primers:</p><p id="__p47">Adenovirus forward primer (5492): 5\'-CTCTTACCTCGCGTCTCCAT-3\'</p><p id="__p48">Adenovirus reverse primer (6084C): 5\'-TCGCCAAGCTTCTCTCCAAC-3\'</p><p id="__p49">Coxsackievirus forward primer (923): 5\'-TTATCAGAGATGGCAGCACC-3\'</p><p id="__p50" class="p p-last">Coxsackievirus reverse primer (1105C): 5\'-CTTGTCCACCGCTGTAGCCT-3</p></div><div id="Sec17" class="sec"><h3 id="Sec17title">Generating viral DNA templates for real time PCR</h3><p id="__p51" class="p p-first-last">Viral DNA isolated from whole blood plasma was used to generate a template for use in real time PCR. 2 &#x003bc;l of DNA from the virus was used with Platinum PCR Master Mix (Invitrogen) and 2 &#x003bc;l of a 10 &#x003bc;M solution of each of the template primers outlined above. The total volume of the reaction was 50 &#x003bc;l. The same PCR parameters were used as were used for viral-specific amplification. The resulting products were run on a 1% agarose gel containing ethidium bromide. The bands were excised and DNA was eluted according to manufacturer\'s instructions (Qiagen).</p></div><div id="Sec18" class="sec"><h3 id="Sec18title">Real Time PCR</h3><p id="__p52" class="p p-first-last">All real time PCR samples were run on a Cepheid Smart Cycler. OmniMix Hs Reagent (Cephied, packged by Takara) was re-suspended in 50 &#x003bc;l of water, which was sufficient for two PCR reactions. 1 &#x003bc;l of the stock virus and 1 &#x003bc;l of each of the template primers (10 &#x003bc;M) were added and mixed. Samples were run at 95&#x000b0;C for 30 sec, 54&#x000b0;C for 15 sec, and 72&#x000b0;C for 20 sec for a total of 40 cycles.</p></div><div id="Sec19" class="sec sec-last"><h3 id="Sec19title">Determination of viral molecules in viral template</h3><p id="__p53" class="p p-first-last">The molecular weight was determined for each of the dsDNA templates generated by PCR. The OD of the resultant DNA was also recorded. The OD, in grams/&#x003bc;l was divided by the molecular weight of the product and the result was equal to moles/&#x003bc;l. This number was then multiplied by Avogadro\'s number (6.022 &#x000d7; 10<sup>23</sup> molecules/mole) and the resulting number is equal to the number of viral DNA molecules per microliter.</p></div></div><div id="idm139977978825600" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139977978825600title">Acknowledgements</h2><div class="sec"><p id="__p71">This study was funded by a grant from the Center for Genetics and Molecular Medicine, University of Louisville.</p></div></div><div id="App1" class="tsec sec headless whole_rhythm"><!--/article/back/app-group/app/--><div id="Sec20" class="sec sec-first"><h3 id="Sec20title">Authors&#x02019; original submitted files for images</h3><p id="__p54" class="p p-first-last">Below are the links to the authors&#x02019; original submitted files for images.<span class="sup-box" id="MOESM1"><a href="/pmc/articles/PMC1950496/bin/12985_2007_278_MOESM1_ESM.ppt" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 1</a><sup>(244K, ppt)</sup></span><span class="sup-box" id="MOESM2"><a href="/pmc/articles/PMC1950496/bin/12985_2007_278_MOESM2_ESM.ppt" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 2</a><sup>(72K, ppt)</sup></span><span class="sup-box" id="MOESM3"><a href="/pmc/articles/PMC1950496/bin/12985_2007_278_MOESM3_ESM.ppt" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 3</a><sup>(291K, ppt)</sup></span><span class="sup-box" id="MOESM4"><a href="/pmc/articles/PMC1950496/bin/12985_2007_278_MOESM4_ESM.ppt" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 4</a><sup>(76K, ppt)</sup></span><span class="sup-box" id="MOESM5"><a href="/pmc/articles/PMC1950496/bin/12985_2007_278_MOESM5_ESM.ppt" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 5</a><sup>(139K, ppt)</sup></span><span class="sup-box" id="MOESM6"><a href="/pmc/articles/PMC1950496/bin/12985_2007_278_MOESM6_ESM.ppt" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 6</a><sup>(151K, ppt)</sup></span><span class="sup-box" id="MOESM7"><a href="/pmc/articles/PMC1950496/bin/12985_2007_278_MOESM7_ESM.ppt" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 7</a><sup>(114K, ppt)</sup></span></p></div></div><div id="idm139977993129040" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139977993129040title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm139977993128912"><p id="__p62" class="p p-first"><strong>Competing interests</strong></p><p id="__p63" class="p p-last">The author(s) declare that they have no competing interests.</p></p><p class="fn sec" id="idm139977993127664"><p id="__p64" class="p p-first"><strong>Authors\' contributions</strong></p><p id="__p65" class="p">ALC: Conducted multiplex (RT)-PCR, cloning, virus-specific PCR, template production and sequencing.</p><p id="__p66" class="p">JS: Optimized the random multiplex (RT)-PCR of RNA viruses.</p><p id="__p67" class="p">ST: Phlebotomy, serum preparation and assisted with the initial development of the 5-VVVVVVVVAA-3\' primers.</p><p id="__p68" class="p">JWE: Provided scientific input regarding the universal application of this approach and assisted with the optimization of the random multiplex (RT)-PCR of RNA viruses.</p><p id="__p69" class="p">JC: Conceived and directed the entire project. Conducted initial multiplex PCR for AV17.</p><p id="__p70" class="p p-last">All authors read and approved the final manuscript.</p></p></div></div><div id="idm139977991079776aff-info" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139977991079776aff-infotitle">Contributor Information</h2><p><span class="fm-affl">Amy L Clem, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.ellivsiuol.esiwg@10melcla" class="oemail">ude.ellivsiuol.esiwg@10melcla</a></span>.</p><p><span class="fm-affl">Jonathan Sims, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamg@smis.t.nahtanoj" class="oemail">moc.liamg@smis.t.nahtanoj</a></span>.</p><p><span class="fm-affl">Sucheta Telang, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.ellivsiuol@gnalet.atehcus" class="oemail">ude.ellivsiuol@gnalet.atehcus</a></span>.</p><p><span class="fm-affl">John W Eaton, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.loa@xodernotae" class="oemail">moc.loa@xodernotae</a></span>.</p><p><span class="fm-affl">Jason Chesney, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.ellivsiuol@yensehc.nosaj" class="oemail">ude.ellivsiuol@yensehc.nosaj</a></span>.</p></div><div id="Bib1" class="tsec sec"><h2 class="head no_bottom_margin" id="Bib1title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="CR1">1. <span class="element-citation">Jackson RJ, Ramsay AJ, Christensen CD, Beaton S, Hall DF, Ramshaw IA. Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox. <span><span class="ref-journal">J Virol. </span>2001;<span class="ref-vol">75</span>(3):1205\xe2\x80\x931210. doi: 10.1128/JVI.75.3.1205-1210.2001.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC114026/">PMC free article</a>]</span> [<a href="/pubmed/11152493" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FJVI.75.3.1205-1210.2001" target="pmc_ext" ref="reftype=other&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Expression+of+mouse+interleukin-4+by+a+recombinant+ectromelia+virus+suppresses+cytolytic+lymphocyte+responses+and+overcomes+genetic+resistance+to+mousepox&amp;author=RJ+Jackson&amp;author=AJ+Ramsay&amp;author=CD+Christensen&amp;author=S+Beaton&amp;author=DF+Hall&amp;volume=75&amp;issue=3&amp;publication_year=2001&amp;pages=1205-1210&amp;pmid=11152493&amp;doi=10.1128/JVI.75.3.1205-1210.2001&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR2">2. <span class="element-citation">Espy MJ, Cockerill IF, Meyer RF, Bowen MD, Poland GA, Hadfield TL, Smith TF. Detection of smallpox virus DNA by LightCycler PCR. <span><span class="ref-journal">J Clin Microbiol. </span>2002;<span class="ref-vol">40</span>(6):1985\xe2\x80\x931988. doi: 10.1128/JCM.40.6.1985-1988.2002.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC130682/">PMC free article</a>]</span> [<a href="/pubmed/12037052" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FJCM.40.6.1985-1988.2002" target="pmc_ext" ref="reftype=other&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Microbiol&amp;title=Detection+of+smallpox+virus+DNA+by+LightCycler+PCR&amp;author=MJ+Espy&amp;author=IF+Cockerill&amp;author=RF+Meyer&amp;author=MD+Bowen&amp;author=GA+Poland&amp;volume=40&amp;issue=6&amp;publication_year=2002&amp;pages=1985-1988&amp;pmid=12037052&amp;doi=10.1128/JCM.40.6.1985-1988.2002&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR3">3. <span class="mixed-citation">Fatal yellow fever in a traveler returning from Amazonas, Brazil, 2002. Jama. 2002, 287 (19): 2499-2500. 10.1001/jama.287.19.2499. [<a href="/pubmed/12025823" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR4">4. <span class="element-citation">Wilson WJ, Strout CL, DeSantis TZ, Stilwell JL, Carrano AV, Andersen GL. Sequence-specific identification of 18 pathogenic microorganisms using microarray technology. <span><span class="ref-journal">Mol Cell Probes. </span>2002;<span class="ref-vol">16</span>(2):119\xe2\x80\x93127. doi: 10.1006/mcpr.2001.0397.</span> [<a href="/pubmed/12030762" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1006%2Fmcpr.2001.0397" target="pmc_ext" ref="reftype=other&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cell+Probes&amp;title=Sequence-specific+identification+of+18+pathogenic+microorganisms+using+microarray+technology&amp;author=WJ+Wilson&amp;author=CL+Strout&amp;author=TZ+DeSantis&amp;author=JL+Stilwell&amp;author=AV+Carrano&amp;volume=16&amp;issue=2&amp;publication_year=2002&amp;pages=119-127&amp;pmid=12030762&amp;doi=10.1006/mcpr.2001.0397&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR5">5. <span class="element-citation">Seo TK, Thorne JL, Hasegawa M, Kishino H. Estimation of effective population size of HIV-1 within a host: a pseudomaximum-likelihood approach. <span><span class="ref-journal">Genetics. </span>2002;<span class="ref-vol">160</span>(4):1283\xe2\x80\x931293.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1462041/">PMC free article</a>]</span> [<a href="/pubmed/11973287" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genetics&amp;title=Estimation+of+effective+population+size+of+HIV-1+within+a+host:+a+pseudomaximum-likelihood+approach&amp;author=TK+Seo&amp;author=JL+Thorne&amp;author=M+Hasegawa&amp;author=H+Kishino&amp;volume=160&amp;issue=4&amp;publication_year=2002&amp;pages=1283-1293&amp;pmid=11973287&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR6">6. <span class="element-citation">Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. <span><span class="ref-journal">Science. </span>1992;<span class="ref-vol">257</span>(5072):967\xe2\x80\x93971. doi: 10.1126/science.1354393.</span> [<a href="/pubmed/1354393" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1126%2Fscience.1354393" target="pmc_ext" ref="reftype=other&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Differential+display+of+eukaryotic+messenger+RNA+by+means+of+the+polymerase+chain+reaction&amp;author=P+Liang&amp;author=AB+Pardee&amp;volume=257&amp;issue=5072&amp;publication_year=1992&amp;pages=967-971&amp;pmid=1354393&amp;doi=10.1126/science.1354393&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR7">7. <span class="element-citation">Nie X, Singh RP. A novel usage of random primers for multiplex RT-PCR detection of virus and viroid in aphids, leaves, and tubers. <span><span class="ref-journal">J Virol Methods. </span>2001;<span class="ref-vol">91</span>(1):37\xe2\x80\x9349. doi: 10.1016/S0166-0934(00)00242-1.</span> [<a href="/pubmed/11164484" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0166-0934(00)00242-1" target="pmc_ext" ref="reftype=other&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol+Methods&amp;title=A+novel+usage+of+random+primers+for+multiplex+RT-PCR+detection+of+virus+and+viroid+in+aphids,+leaves,+and+tubers&amp;author=X+Nie&amp;author=RP+Singh&amp;volume=91&amp;issue=1&amp;publication_year=2001&amp;pages=37-49&amp;pmid=11164484&amp;doi=10.1016/S0166-0934(00)00242-1&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR8">8. <span class="element-citation">Ralph D, McClelland M, Welsh J. RNA fingerprinting using arbitrarily primed PCR identifies differentially regulated RNAs in mink lung (Mv1Lu) cells growth arrested by transforming growth factor beta 1. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1993;<span class="ref-vol">90</span>(22):10710\xe2\x80\x9310714. doi: 10.1073/pnas.90.22.10710.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC47847/">PMC free article</a>]</span> [<a href="/pubmed/8248163" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1073%2Fpnas.90.22.10710" target="pmc_ext" ref="reftype=other&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=RNA+fingerprinting+using+arbitrarily+primed+PCR+identifies+differentially+regulated+RNAs+in+mink+lung+(Mv1Lu)+cells+growth+arrested+by+transforming+growth+factor+beta+1&amp;author=D+Ralph&amp;author=M+McClelland&amp;author=J+Welsh&amp;volume=90&amp;issue=22&amp;publication_year=1993&amp;pages=10710-10714&amp;pmid=8248163&amp;doi=10.1073/pnas.90.22.10710&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR9">9. <span class="element-citation">van den Hoogen BG, de Jong JC, Groen J, Kuiken T, de Groot R, Fouchier RA, Osterhaus AD. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. <span><span class="ref-journal">Nat Med. </span>2001;<span class="ref-vol">7</span>(6):719\xe2\x80\x93724. doi: 10.1038/89098.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7095854/">PMC free article</a>]</span> [<a href="/pubmed/11385510" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2F89098" target="pmc_ext" ref="reftype=other&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;title=A+newly+discovered+human+pneumovirus+isolated+from+young+children+with+respiratory+tract+disease&amp;author=BG+van+den+Hoogen&amp;author=JC+de+Jong&amp;author=J+Groen&amp;author=T+Kuiken&amp;author=R+de+Groot&amp;volume=7&amp;issue=6&amp;publication_year=2001&amp;pages=719-724&amp;pmid=11385510&amp;doi=10.1038/89098&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR10">10. <span class="element-citation">Reyes GR, Kim JP. Sequence-independent, single-primer amplification (SISPA) of complex DNA populations. <span><span class="ref-journal">Mol Cell Probes. </span>1991;<span class="ref-vol">5</span>(6):473\xe2\x80\x93481. doi: 10.1016/S0890-8508(05)80020-9.</span> [<a href="/pubmed/1664049" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0890-8508(05)80020-9" target="pmc_ext" ref="reftype=other&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cell+Probes&amp;title=Sequence-independent,+single-primer+amplification+(SISPA)+of+complex+DNA+populations&amp;author=GR+Reyes&amp;author=JP+Kim&amp;volume=5&amp;issue=6&amp;publication_year=1991&amp;pages=473-481&amp;pmid=1664049&amp;doi=10.1016/S0890-8508(05)80020-9&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR11">11. <span class="element-citation">Matsui SM, Kim JP, Greenberg HB, Su W, Sun Q, Johnson PC, DuPont HL, Oshiro LS, Reyes GR. The isolation and characterization of a Norwalk virus-specific cDNA. <span><span class="ref-journal">J Clin Invest. </span>1991;<span class="ref-vol">87</span>(4):1456\xe2\x80\x931461. doi: 10.1172/JCI115152.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC295196/">PMC free article</a>]</span> [<a href="/pubmed/2010555" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1172%2FJCI115152" target="pmc_ext" ref="reftype=other&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&amp;title=The+isolation+and+characterization+of+a+Norwalk+virus-specific+cDNA&amp;author=SM+Matsui&amp;author=JP+Kim&amp;author=HB+Greenberg&amp;author=W+Su&amp;author=Q+Sun&amp;volume=87&amp;issue=4&amp;publication_year=1991&amp;pages=1456-1461&amp;pmid=2010555&amp;doi=10.1172/JCI115152&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR12">12. <span class="element-citation">Allander T, Emerson SU, Engle RE, Purcell RH, Bukh J. A virus discovery method incorporating DNase treatment and its application to the identification of two bovine parvovirus species. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2001;<span class="ref-vol">98</span>(20):11609\xe2\x80\x9311614. doi: 10.1073/pnas.211424698.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC58777/">PMC free article</a>]</span> [<a href="/pubmed/11562506" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1073%2Fpnas.211424698" target="pmc_ext" ref="reftype=other&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=A+virus+discovery+method+incorporating+DNase+treatment+and+its+application+to+the+identification+of+two+bovine+parvovirus+species&amp;author=T+Allander&amp;author=SU+Emerson&amp;author=RE+Engle&amp;author=RH+Purcell&amp;author=J+Bukh&amp;volume=98&amp;issue=20&amp;publication_year=2001&amp;pages=11609-11614&amp;pmid=11562506&amp;doi=10.1073/pnas.211424698&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR13">13. <span class="element-citation">Kuiken T, Fouchier RA, Schutten M, Rimmelzwaan GF, van Amerongen G, van Riel D, Laman JD, de Jong T, van Doornum G, Lim W, Ling AE, Chan PK, Tam JS, Zambon MC, Gopal R, Drosten C, van der Werf S, Escriou N, Manuguerra JC, Stohr K, Peiris JS, Osterhaus AD. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. <span><span class="ref-journal">Lancet. </span>2003;<span class="ref-vol">362</span>(9380):263\xe2\x80\x93270. doi: 10.1016/S0140-6736(03)13967-0.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7112434/">PMC free article</a>]</span> [<a href="/pubmed/12892955" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0140-6736(03)13967-0" target="pmc_ext" ref="reftype=other&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Newly+discovered+coronavirus+as+the+primary+cause+of+severe+acute+respiratory+syndrome&amp;author=T+Kuiken&amp;author=RA+Fouchier&amp;author=M+Schutten&amp;author=GF+Rimmelzwaan&amp;author=G+van+Amerongen&amp;volume=362&amp;issue=9380&amp;publication_year=2003&amp;pages=263-270&amp;pmid=12892955&amp;doi=10.1016/S0140-6736(03)13967-0&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR14">14. <span class="element-citation">Peiris JS, Lai ST, Poon LL, Guan Y, Yam LY, Lim W, Nicholls J, Yee WK, Yan WW, Cheung MT, Cheng VC, Chan KH, Tsang DN, Yung RW, Ng TK, Yuen KY. Coronavirus as a possible cause of severe acute respiratory syndrome. <span><span class="ref-journal">Lancet. </span>2003;<span class="ref-vol">361</span>(9366):1319\xe2\x80\x931325. doi: 10.1016/S0140-6736(03)13077-2.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7112372/">PMC free article</a>]</span> [<a href="/pubmed/12711465" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0140-6736(03)13077-2" target="pmc_ext" ref="reftype=other&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Coronavirus+as+a+possible+cause+of+severe+acute+respiratory+syndrome&amp;author=JS+Peiris&amp;author=ST+Lai&amp;author=LL+Poon&amp;author=Y+Guan&amp;author=LY+Yam&amp;volume=361&amp;issue=9366&amp;publication_year=2003&amp;pages=1319-1325&amp;pmid=12711465&amp;doi=10.1016/S0140-6736(03)13077-2&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1950496&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC1950496/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC1950496/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC1950496/pdf/12985_2007_Article_278.pdf">PDF (1.3M)</a></li> | <li><a href="#" data-citationid="PMC1950496" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1950496%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1950496%2F&amp;text=Virus%20detection%20and%20identification%20using%20random%20multiplex%20(RT)-PCR%20with%203\'-locked%20random%20primers"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1950496%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="17598900" data-aiid="7095495" data-aid="1950496" data-iid="354810" data-domainid="3814" data-domain="phenaturepg" data-accid="PMC1950496" data-md5="be0050c8e2371bfb81afd4fbccabaa62"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T09:31:20-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc101&amp;ncbi_phid=8A1A07F6E99A6BE10000000005F605F6&amp;ncbi_session=8A1A07F6E99AFA71_1526SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1950496%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=phenaturepg&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC1950496/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1A07F6E99AFA71_1526SID /projects/PMC/PMCViewer@4.46 ptpmc101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'